Patricia V. Schoenlein
Affiliations: | Medical College of Georgia, Augusta, GA, United States |
Area:
Oncology, Cell Biology, Molecular BiologyGoogle:
"Patricia Schoenlein"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
McGrath MK, Abolhassani A, Guy L, et al. (2024) Autophagy and senescence facilitate the development of antiestrogen resistance in ER positive breast cancer. Frontiers in Endocrinology. 15: 1298423 |
Elshazly AM, Sinanian MM, Neely V, et al. (2023) BRD4 Inhibition as a Strategy to Prolong the Response to Standard of Care in Estrogen Receptor-Positive Breast Cancer. Cancers. 15 |
Hagan ML, Mander S, Joseph C, et al. (2022) Upregulation of the EGFR/MEK1/MAPK1/2 signaling axis as a mechanism of resistance to antiestrogen‑induced BimEL dependent apoptosis in ER breast cancer cells. International Journal of Oncology. 62 |
Finnegan RM, Elshazly AM, Schoenlein PV, et al. (2022) Therapeutic Potential for Targeting Autophagy in ER+ Breast Cancer. Cancers. 14 |
Herrington K, Joseph C, Abdulmoneim S, et al. (2020) Abstract 1231: Targeting JNK1/2 induces a potent cytostatic response in estrogen receptor expressing breast cancer cells, with induction of autophagy and senescence as measurable outcomes Cancer Research. 80: 1231-1231 |
Meghil MM, Tawfik OK, Elashiry M, et al. (2019) Disruption of Immune Homeostasis in Human Dendritic Cells via Regulation of Autophagy and Apoptosis by . Frontiers in Immunology. 10: 2286 |
Munagala R, Joseph C, Liu A, et al. (2017) Abstract 3318: A critical role for c-Jun N-terminal kinase in autophagy and cell survival of breast cancer cells Cancer Research. 77: 3318-3318 |
Liu F, Li X, Lu C, et al. (2016) Ceramide activates lysosomal cathepsin B and cathepsin D to attenuate autophagy and induces ER stress to suppress myeloid-derived suppressor cells. Oncotarget |
Conger J, Manning M, Anosike K, et al. (2016) Abstract 4672: Targeting MEK/MAPK1/2in vivoto eradicate antiestrogen resistance Cancer Research. 76: 4672-4672 |
Manning M, Takhar S, Periyasamy-Thandavan S, et al. (2015) Abstract 1005: Dual targeting of MEK/MAPK1/2 and pro-survival autophagy to optimize antiestrogen treatment toward the eradication of antiestrogen resistant breast cancer Cancer Research. 75: 1005-1005 |